- Home
- GHRS vs ICHR Comparison
GHRS vs ICHR Comparison
Compare GHRS & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- ICHR
- Stock Information
- Founded
- GHRS 2018
- ICHR 1999
- Country
- GHRS Ireland
- ICHR United States
- Employees
- GHRS N/A
- ICHR N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- ICHR Semiconductors
- Sector
- GHRS Health Care
- ICHR Technology
- Exchange
- GHRS Nasdaq
- ICHR Nasdaq
- Market Cap
- GHRS 849.8M
- ICHR 727.6M
- IPO Year
- GHRS 2021
- ICHR 2016
- Fundamental
- Price
- GHRS $12.31
- ICHR $17.21
- Analyst Decision
- GHRS Strong Buy
- ICHR Strong Buy
- Analyst Count
- GHRS 8
- ICHR 6
- Target Price
- GHRS $30.63
- ICHR $35.20
- AVG Volume (30 Days)
- GHRS 187.6K
- ICHR 439.1K
- Earning Date
- GHRS 05-08-2025
- ICHR 08-05-2025
- Dividend Yield
- GHRS N/A
- ICHR N/A
- EPS Growth
- GHRS N/A
- ICHR N/A
- EPS
- GHRS N/A
- ICHR N/A
- Revenue
- GHRS N/A
- ICHR $892,122,000.00
- Revenue This Year
- GHRS N/A
- ICHR $14.18
- Revenue Next Year
- GHRS N/A
- ICHR $6.66
- P/E Ratio
- GHRS N/A
- ICHR N/A
- Revenue Growth
- GHRS N/A
- ICHR 13.41
- 52 Week Low
- GHRS $6.00
- ICHR $15.33
- 52 Week High
- GHRS $20.50
- ICHR $42.70
- Technical
- Relative Strength Index (RSI)
- GHRS 52.37
- ICHR 44.38
- Support Level
- GHRS $12.43
- ICHR $17.58
- Resistance Level
- GHRS $13.15
- ICHR $19.74
- Average True Range (ATR)
- GHRS 0.99
- ICHR 0.81
- MACD
- GHRS -0.14
- ICHR 0.04
- Stochastic Oscillator
- GHRS 41.03
- ICHR 42.63
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.